T helper (Th)17 cells have been shown to play a role in the pathogenesis of inflammatory and autoimmune diseases such as the inflammatory bowel diseases (IBD). 1, 2 It is now well established that although transforming growth factor (TGF)-alone induces FoxP3 + regulatory T (Treg) cells, TGF-, and interleukin (IL)-6, acting in concert, induce the differentiation of mouse naive T cells into Th17 cells by upregulating the retinoidrelated orphan receptor-t. 3 -6 As we previously reported that CD4 + CD25 + Foxp3 + " natural " Treg cells express cell surface or secrete TGF-in both mouse and human Tregs, our findings prompted us to investigate the possibility that Treg cells play a role in such Th17 differentiation. 7, 8 
CD25 + FOXP3 + BUT NOT CD25 + FOXP3 − T CELLS EXPRESS SURFACE TGF-
In an earlier study, we observed that CD4 + CD25 + Treg cells stained with anti-latent-associated peptide antibody were also FoxP3-positive using confocal fluorescence microscopy. 9 Latent-associated peptide-positive staining suggests the expression of a latent form of membrane TGF-on Treg, not the active TGF-bound to the TGF-receptors on Treg cells. In contrast, CD4 + CD25 − T cells were mostly negative in both latent-associated peptide and FoxP3 staining. After stimulation with anti-CD3 and anti-CD28 antibodies, activated Treg cells exhibited strongly enhanced latent-associated peptide staining, which could be expected to exhibit a stronger effect on membrane TGF--mediated Th17 differentiation of CD4 + CD25 − T cells.
CD4 + CD25 + FOXP3 + TREG CELLS INDUCE CD4 + CD25 − CELLS TO BECOME IL-17-PRODUCING CELLS
To facilitate the analysis of IL-17 differentiation mediated by FoxP3 + Treg cells, we used green fluorescent protein (GFP) knock-in mice kindly provided by Mohamed Oukka (Center of Neurologic Diseases, Harvard Medical School), in which IRES-GFP is inserted downstream of the stop codon of FoxP3 gene. 5 Using this GFP knock-in mouse, we found that addition of IL-6 alone (without TGF-) to the coculture of fresh CD4 + GFP + T cells with CD4 + GFP − T cells obtained by flow cytometric cell sorting led to the appearance of a low number of IL-17-positive cells at a 1:1 cell (GFP + / GFP − ) ratio (1.8 % ) and a somewhat increased number of these at a 2:1 ratio (5.8 % ), whereas addition of IL-6 to the coculture of preactivated CD4 + FoxP3 + T cells with fresh CD4 + FoxP3 − T cells led to a cell population containing approximately 25.9 % IL-17-producing cells at a 1:1 cell ratio without exogenous addition of TGF-, but the coculture of preactivated CD4 + FoxP3 − T cells led to a cell population containing virtually no IL-17-producing cells ( Figure 1 In further studies, we determined the cellular source of TGFin these cultures by intracellular staining with anti-TGF-. As shown in Figure 3 , the GFP + Treg cell population contained a subpopulation of TGF--containing cells that was larger and more intensely stained than that in the CD4 + GFP − T cell population. 10 In addition, the dendritic cell (DC) population also contained a TGF--positive subpopulation and when these cells were co-cultured with GFP + Treg cells, the TGF--positive subpopulation was greatly increased. Thus, Treg cells augment the induction of IL-17-producing cells in two ways: they produce TGF-themselves and they induce DCs to produce increased amounts of TGF-. The latter point is important, as during the amelioration of established colitis Treg cells have been shown to be located between clusters of CD11c + cells and pathogenic T cells, and thus in contact with both cell types. 11 In addition, in a study of nonobese diabetic mice, using two photon laser-scanning microscopy to analyze priming of diabetogenic T cells and their control by Treg cells, it was found that Treg cells did not form detectable stable associations with Th cells, but did form stable associations with DCs bearing islet antigen. 12 These studies delineate the importance of interaction between Treg cells and DCs in vivo and thus establish the possibility that Treg cells induce DCs to produce TGF-. 
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THE POSSIBLE ROLE OF TREG DIFFERENTIATION INTO TH17 CELLS IN COLITIS MODELS AND IN HUMAN IBD
Our finding that Treg cells induce the differentiation of CD4 + CD25 − T cells into Th17 cells or self-induce into Th17 cells was further studied in 2,4,6-trinitrobenzenesulfonic acid colitis, a mouse model of human colitis. The available data showed that mice develop a more severe 2,4,6-trinitrobenzenesulfonic acid colitis accompanied by increased IL-17 production when they were administered Foxp3 + (GFP + ) Treg cells during the development of colitis. These data provide preliminary support for the idea that Treg cells contribute to Th17 differentiation in vivo under inflammatory conditions and therefore could be playing a role in the course of the inflammation.
Recently, the conditions necessary for the differentiation of human Th17 have been reported. In contrast to the murine system, human Th17 differentiation was induced by IL-1 and IL-23 and enhanced by IL-6 but was suppressed by TGF-and IL-12. 13, 14 In keeping with this, our preliminary findings suggest that human Treg cells can be induced to a Th17 state by IL-6 and IL-1 .
SIGNIFICANCE OF TH17 CELLS INDUCED BY AND / OR CONVERTED FROM TREG CELLS
A summary of our findings relating to Treg cell-mediated Th17 differentiation is provided in Figure 4 . What is the significance of Th17 cells induced by and / or converted from Treg cells?
One possibility is that Treg cells contribute to the differentiation of Th17 cells and the latter, in turn, produce IL-17 and IL-22 cytokines that help to maintain mucosal barrier function. 15 These cells, therefore help to maintain mucosal homeostasis in the absence of infection and improve the host defense response in the presence of infection. Another possibility is that the interconversion of Treg cells and Th17 has undesirable effects. Here, it should be noted that both CD4 + CD25 + and CD4 + CD25 bright T cells in the lamina propria were found to be significantly increased in patients with active Crohn ' s disease or active ulcerative colitis as compared with normal individuals. 16, 17 Although these Treg cells have been shown to possess suppressive activity in in vitro suppression assay, it is possible that some of these Treg cells may make an undesirable contribution to the differentiation of pathogenic Th17, especially as they exist in a milieu that contains the cytokines (such as IL-6, IL-1 , and IL-23) that can convert them into Th17 cells. Recently, it was shown that although TGF-and IL-6 drive initial Th17 lineage commitment, the pathogenic potential of Th17 cells are restrained by the coproduction of IL-10. Only when the Th17 cells are exposed to IL-23 they cease IL-10 production and attain their full pathogenic function. 18 Whether or not Th17 cells in any state of differentiation can be converted into Treg cells remains to be seen. Clearly, further study of the relationship between Treg cells and Th17 cells in the inflamed tissue of IBD patients is important to the understanding of the consequences of Treg cell administration in the treatment of inflammatory diseases.
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